Oral bacteria in pancreatic cancer: Mutagenesis of the p53 tumour suppressor gene

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 11835-11836

  Öğrendik, Mesut ^a  

^a Selcuk State Hospital Division Physical Therapy and Rheumatology   (Turkey)

Author keywords

Arginine; Oral bacteria; P53 mutation; Pancreatic cancer

Indexed keywords

BACTERIUM ANTIBODY; HYDROLASE; PROTEIN P53; TP53 PROTEIN, HUMAN; TUMOR MARKER;

CARCINOMA; CELL TRANSFORMATION; ENZYMOLOGY; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUTH; MUTATION; PANCREAS TUMOR; PATHOLOGY; PORPHYROMONAS GINGIVALIS; RISK FACTOR;

ANTIBODIES, BACTERIAL; BIOMARKERS, TUMOR; CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; HYDROLASES; MOUTH; MUTATION; PANCREATIC NEOPLASMS; PORPHYROMONAS GINGIVALIS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 85006140326     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-902.
2. Office for National Statistics. Cancer Statistics Registrations Series MB1. London, England; 2011.
3. Boyle P, Hsieh CC, Maisonneuve P, La Vecchia C, Macfarlane GJ, Walker AM, Trichopoulos D. Epidemiology of pancreas cancer. Int J Pancreatol 1989; 5: 327-4.
4. Michaud DS. Role of bacterial infections in pancreatic cancer. Carcinogenesis 2013; 34: 2193-7.
5. Jotwani R, Cutler CW. Adult periodontitis-specific bacterial infection or chronic inflammation? J Med Microbiol 1998; 47: 187-8.
6. Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis 2012; 33: 1055-8.
7. In: Marsh PD, Martin MV, editors. Oral Microbiology. 4th edition. Bodmin: MPG Books Ltd; 2001.
8. Michaud DS, Izard J, Wilhelm-Benartzi CS, You DH, Grote VA, Tjønneland A, Dahm CC, Overvad K, Jenab M, Fedirko V, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Kaaks R, Boeing H, Foerster J, Trichopoulou A, Lagiou P, Trichopoulos D, Sacerdote C, Sieri S, Palli D, Tumino R, Panico S, Siersema PD, Peeters PH, Lund E, Barricarte A, Huerta JM, Molina-Montes E, Dorronsoro M, Quirós JR, Duell EJ, Ye W, Sund M, Lindkvist B, Johansen D, Khaw KT, Wareham N, Travis RC, Vineis P, Bueno-de-Mesquita HB, Riboli E. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Gut 2013; 62: 1764-70.
9. Barton CM, Staddon SL, Hughes CM, Hall PA, O'Sullivan C, Klöppel G, Theis B, Russell RC, Neoptolemos J, Williamson RC. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer 1991; 64: 1076-82.
10. Liu L, Wang K, Zhu ZM, Shao JH. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Arch Med Res 2011; 42: 60-9.